February 21, 2018 / 9:14 PM / 4 months ago

BRIEF-Ligand Posts Q4 Adjusted Earnings Per Share $1.31

Feb 21 (Reuters) - Ligand Pharmaceuticals Inc:

* LIGAND REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS

* Q4 REVENUE $50.5 MILLION

* ‍AS OF DECEMBER 31, 2017, LIGAND HAD CASH, CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS OF $201.7 MILLION​

* ‍ESTIMATES THAT CASH EXPENSES FOR 2018 WILL BE IN RANGE OF $34 MILLION TO $35 MILLION​

* WITH REVENUE OF $164 MILLION, ADJUSTED EARNINGS PER DILUTED SHARE WOULD BE ABOUT $4.22 FOR 2018​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below